Search - tctmd.com

Displaying 481 - 500 of 556

Sort: Relevancy | Date

Presentation TCT 2014

Comparison of Peripheral Arterial Chronic Total Occlusion Crossing Strategies in the XLPAD Registry

Presenter: Karan Sarode

September 16, 2014

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

Presentation TCT 2014

Unmet Technical Needs and Opportunities for the Development of Next-Generation Technologies

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Marianne Brodmann

September 15, 2014

Presentation TCT 2014

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Lawrence A. Garcia

September 15, 2014

Presentation TCT 2014

CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All!

Presenter: Dierk Scheinert

September 15, 2014

Presentation TCT 2014

PRO: IN.PACT DEEP was Flawed!

Presenter: Francesco Liistro

September 15, 2014

Presentation TCT 2014

Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Peter A. Schneider

September 15, 2014

Presentation TCT 2014

TCT 269: Drug-Coated Balloon vs Standard Balloon for the PTA Treatment of Lesions in the SFA and Popliteal Artery? First Interim Results of the FREERIDE Study

Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Schulte Karl-Ludwig, MD

September 15, 2014

Presentation TCT 2014

TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial

Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Adam Salisbury, MD

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Arne Schwindt

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices II: Atherectomy - Insights from The DEFINITE AR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gunnar Tepe

September 15, 2014

Presentation TCT 2014

TCT 346: Relationship Between Peripheral Artery Disease and Coronary Plaque Morphology: An ADAPT-DES Intravascular Ultrasound Substudy

Presenter: Charles J. Davidson, Robert J. Russo, Ryan D. Madder, Mitsuaki Matsumura

September 15, 2014

Presentation TCT 2014

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Francesco Liistro

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gary M. Ansel

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World II: DCB for Long and Highly Calcified Vessels

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gunnar Tepe

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

Randomized Controlled Trials I: Extended Follow-Up From LEVANT 2 - Analysis of one year Follow-up and Beyond

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

Randomized Controlled Trials I: New Insights From INPACT SFA II

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, John R. Laird Jr

September 15, 2014

Presentation TCT 2014

Enhanced Effects of Primed Peripheral Monocytes

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Hyo-Soo Kim

September 15, 2014

Presentation TCT 2014

DCB in De Novo Lesions: Critical Review of FIH Data, Efficacy, and Long-term Durability

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Advertisement

Comparison of Peripheral Arterial Chronic Total Occlusion Crossing Strategies in the XLPAD Registry

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

Unmet Technical Needs and Opportunities for the Development of Next-Generation Technologies

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All!

PRO: IN.PACT DEEP was Flawed!

Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy

TCT 269: Drug-Coated Balloon vs Standard Balloon for the PTA Treatment of Lesions in the SFA and Popliteal Artery? First Interim Results of the FREERIDE Study

TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial

DCB and the Use of Ancillary Devices III: Unmet Technical Needs and Opportunities for Development of Next-Generation Technologies

DCB and the Use of Ancillary Devices II: Atherectomy - Insights from The DEFINITE AR Trial

TCT 346: Relationship Between Peripheral Artery Disease and Coronary Plaque Morphology: An ADAPT-DES Intravascular Ultrasound Substudy

DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use?

DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

DCB Use in the Real World II: DCB for Long and Highly Calcified Vessels

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

Randomized Controlled Trials I: Extended Follow-Up From LEVANT 2 - Analysis of one year Follow-up and Beyond

Randomized Controlled Trials I: New Insights From INPACT SFA II

Enhanced Effects of Primed Peripheral Monocytes

DCB in De Novo Lesions: Critical Review of FIH Data, Efficacy, and Long-term Durability

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content